期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Hip International LetPub Score 5.0
50 ratings
Rate
Reputation 6.3 Influence 3.6 Speed 6.9 | ||||||||||||||||||||
期刊簡稱 | HIP INT | ||||||||||||||||||||
ISSN | 1120-7000 | ||||||||||||||||||||
E-ISSN | 1724-6067 | ||||||||||||||||||||
h-index | 31 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.hip-int.com/ | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/HIPINT | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Wichtig Publishing Srl | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | ITALY | ||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||
創刊年 | 1991 | ||||||||||||||||||||
每年文章數 | 61每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 10.57% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1120-7000%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 100% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Hip International] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:26:11 評論於 Choose the issue you want to discuss in depth; Discuss the selected issue from multiple perspectives at a certain level, reasoning must be based, the problem must be clearly and thoroughly explained(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:28:47 評論於 Highlight the innovativeness of your research, showcasing distinct features that set you apart from others. The degree of differentiation is another matter, but the key is to have some form of contrast. As long as there is a distinction, it can be considered innovative(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 12:01:48 評論於 What is a deep discussion and how to deepen the discussion?(0) 讚! | 深渊兴业 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:42:16 評論於 How to highlight the innovativeness of an article in a discussion?(0) 讚! | Oswald Edie |
作者: 黄桂雄 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-29 19:24:40 評論於 Unable to submit the manuscript.(0) 讚! | 黄桂雄 |
作者: Oliver Jerry 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-25 20:26:53 評論於 Well said(0) 讚! | Oliver Jerry |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 22:01:31 評論於 Cross the one-point threshold, may the gods bless us!! Let's aim for more than two points next year(0) 讚! | 凌霄高洁 |
作者: 璧射妙绿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-06-11 22:49:53 評論於 Review Speed: 12.0 | Submission Hit Rate: 50.0 Experience Sharing: Submitted in November 2015, reviewed over two months later, received revisions at the end of February 2016. Resubmitted in early March, no response since then, resubmitted again in mid to late April, accepted after two months of review. Although it was accepted, it is not recommended to submit to small journals with an annual publication of only around 80 articles, low impact factor, the review process is really long! Overall, even estimating it to be faster, it still takes around 9 months(0) 讚! | 璧射妙绿 |
作者: 风神洪滨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-20 23:33:16 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: The review speed of the journal is relatively slow, there is a page fee, hoping for an increase in Impact Factor(0) 讚! | 风神洪滨 |
作者: 太山望舒 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-05-07 08:22:00 評論於 Review speed: 2.0 | Submission hit rate: 75.0 Experience sharing: A case report on children with acetabular osteoid osteoma leading to joint deformity was submitted, and the condition was observed for 1 year. The data was detailed, and the article was accepted for publication directly after 49 days of submission(0) 讚! | 太山望舒 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2009-12-12 22:09:01 評論於 Agree with the above statement, my application was rejected after 6 weeks of review(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2009-11-15 09:33:11 評論於 Submitting is easy, and we will send you a review after acceptance, but we will not select your submission(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us